Direct rosiglitazone action on steroidogenesis and proinflammatory factor production in human granulosa-lutein cells

BACKGROUND: Ovarian granulosa cells are the predominant source of estradiol and progesterone biosynthesis in vivo. Rosiglitazone, a synthetic agonist of the peroxisome proliferator-activated receptor gamma (PPAR gamma), is applied as the treatment of insulin resistance including women with PCOS. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qiuju, Sun, Xiaoxi, Chen, Junling, Cheng, Linan, Wang, Jian, Wang, Yongwei, Sun, Zhaogui
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797791/
https://www.ncbi.nlm.nih.gov/pubmed/20003221
http://dx.doi.org/10.1186/1477-7827-7-147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797791/
https://www.ncbi.nlm.nih.gov/pubmed/20003221
http://dx.doi.org/10.1186/1477-7827-7-147

Ejemplares similares